Horizon Discovery announces new CFO
21.08.2012 - Horizon Discovery appointed Richard Vellacott as its new Chief Financial Officer. Vellacott has over 15 years’ experience in working with life sciences companies, from start-ups to global pharmaceuticals.
Prior to joining Horizon, he was Vice President Finance at CSR plc. During his time at CSR, Vellacott had worldwide responsibility for finance, making significant contributions to the transformational acquisition and integration of NASDAQ-listed Zoran Corp., product portfolio management, R&D budgeting and business investment. Before this, he was a Director in Deloitte’s life sciences practice, where he specialised in capital market transactions including IPOs, M&A and fundraising on both the UK and the US markets. Horizon Discovery Limited (“Horizon”) is a leading provider of research tools to support the development of personalised medicines.http://www.european-biotechnology-news.com/people/bio-people/2012-2/richard-vellacott.html